Guillain-Barré syndrome following COVID-19 vaccine: A case report

Mohammad Sadegh Fakhari; Leila Poorsaadat; Behnam Mahmoodiyeh

doi:10.1002/ccr3.6451

Guillain-Barré syndrome following COVID-19 vaccine: A case report

Clin Case Rep. 2022 Oct 13;10(10):e6451. doi: 10.1002/ccr3.6451. eCollection 2022 Oct.

Authors

Mohammad Sadegh Fakhari¹, Leila Poorsaadat², Behnam Mahmoodiyeh³

Affiliations

¹ Student Research Committee Arak University of Medical Sciences Arak Iran.
² Department of Neurology, School of Medicine Arak University of Medical Sciences Arak Iran.
³ Department of Anesthesiology, School of Medicine Arak University of Medical Sciences Arak Iran.

Abstract

Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID-19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we report a case of Guillain-Barré Syndrome Following Sinopharm COVID-19 Vaccine.

Keywords: COVID‐19; Guillain–Barré syndrome; case report; sinopharm vaccine.

Publication types

Case Reports